▶ 調査レポート

ボツリヌス毒素の世界市場レポート2020

• 英文タイトル:Global Botulinum Toxins Sales Market Report 2020

QYResearchが調査・発行した産業分析レポートです。ボツリヌス毒素の世界市場レポート2020 / Global Botulinum Toxins Sales Market Report 2020 / 20QY06-03756資料のイメージです。• レポートコード:20QY06-03756
• 出版社/出版日:QYResearch / 2020年6月3日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、130ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医薬品・医療
• 販売価格(消費税別)
  Single User¥592,000 (USD4,000)▷ お問い合わせ
  Multi User¥888,000 (USD6,000)▷ お問い合わせ
  Enterprise License¥1,184,000 (USD8,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社の当調査資料では、ボツリヌス毒素のグローバル市場について種類別(50U、100U、その他)、用途別(医療、化粧品)、地域別(北米、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。

・ボツリヌス毒素市場の概要
・世界の主要地域別ボツリヌス毒素市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界のボツリヌス毒素市場規模2015-2026:種類別(50U、100U、その他)
・世界のボツリヌス毒素市場規模2015-2026:用途別(医療、化粧品)
・ボツリヌス毒素の北米市場規模2015-2020
・ボツリヌス毒素のヨーロッパ市場規模2015-2020
・ボツリヌス毒素の中国市場規模2015-2020
・ボツリヌス毒素の日本市場規模2015-2020
・ボツリヌス毒素の東南アジア市場規模2015-2020
・ボツリヌス毒素のインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
(Allergan、、Ipsen、、Medytox、、LIBP、、Merz Pharmaceuticals、、US World Meds、)
・ボツリヌス毒素の製造コスト分析
・販売チャネル、流通業者、顧客
・ボツリヌス毒素の市場動向・機会・課題
・調査の結論

A recently published report by QY Research titled Global Botulinum Toxins Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Botulinum Toxins market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.

QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.

Report Overview:

Botulinum toxin (BTX) is a neurotoxic protein produced by the bacterium Clostridium botulinum and related species. It prevents the release of the neurotransmitter acetylcholine from axon endings at the neuromuscular junction and thus causes flaccid paralysis. Infection with the bacterium causes the disease botulism. The toxin is also used commercially in medicine, cosmetics and research.

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Botulinum Toxins market in 2020.

COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.

The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

This report also analyses the impact of Coronavirus COVID-19 on the Botulinum Toxins industry.

Based on our recent survey, we have several different scenarios about the Botulinum Toxins YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 5205.7 million in 2019. The market size of Botulinum Toxins will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.

QY Research report provides an overview and scope of the global Botulinum Toxins market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Botulinum Toxins market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.

QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Botulinum Toxins market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Botulinum Toxins market. The report also includes nautical information, where it shows Botulinum Toxins market product volume, utilization value, and production processes.

The research report also consists of a competitive landscape that describes the top players that are functioning in the global Botulinum Toxins market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Botulinum Toxins market.

North America is estimated to have a major share in the global market with 80%.

Geographical Analysis:

Based on region, the global Botulinum Toxins market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.

Key Players:

The major players that are operating in the global Botulinum Toxins market are

Allergan

Ipsen

Medytox

LIBP

Merz Pharmaceuticals

US World Meds

Segment by Type

50U

100U

Other

The sales proportion of 50U in 2018 is about 59%.

Segment by Application

Medical

Cosmetic

The medical holds an important share in terms of applications, and accounts for 51% of the market share.

Competitive Landscape:

Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Botulinum Toxins market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.

The report covers the following objectives:

• Proliferation and maturation of trade in the global Botulinum Toxins market.

• The market share of the global Botulinum Toxins market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.

• Current and future market trends that are influencing the growth opportunities and growth rate of the global Botulinum Toxins market.

• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Botulinum Toxins market.

レポート目次

1 Botulinum Toxins Market Overview

1.1 Botulinum Toxins Product Scope

1.2 Botulinum Toxins Segment by Type

1.2.1 Global Botulinum Toxins Sales by Type (2020-2026)

1.2.2 50U

1.2.3 100U

1.2.4 Other

1.3 Botulinum Toxins Segment by Application

1.3.1 Global Botulinum Toxins Sales Comparison by Application (2020-2026)

1.3.2 Medical

1.3.3 Cosmetic

1.4 Botulinum Toxins Market Estimates and Forecasts (2015-2026)

1.4.1 Global Botulinum Toxins Sales Growth Rate (2015-2026)

1.4.2 Global Botulinum Toxins Revenue and Growth Rate (2015-2026)

1.4.3 Global Botulinum Toxins Price Trends (2015-2026)

1.5 Coronavirus Disease 2019 (Covid-19): Botulinum Toxins Industry Impact

1.5.1 How the Covid-19 is Affecting the Botulinum Toxins Industry

1.5.1.1 Botulinum Toxins Business Impact Assessment – Covid-19

1.5.1.2 Supply Chain Challenges

1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products

1.5.2 Market Trends and Botulinum Toxins Potential Opportunities in the COVID-19 Landscape

1.5.3 Measures / Proposal against Covid-19

1.5.3.1 Government Measures to Combat Covid-19 Impact

1.5.3.2 Proposal for Botulinum Toxins Players to Combat Covid-19 Impact

2 Botulinum Toxins Estimate and Forecast by Region

2.1 Global Botulinum Toxins Market Size by Region: 2015 VS 2020 VS 2026

2.2 Global Botulinum Toxins Retrospective Market Scenario by Region (2015-2020)

2.2.1 Global Botulinum Toxins Sales Market Share by Region (2015-2020)

2.2.2 Global Botulinum Toxins Revenue Market Share by Region (2015-2020)

2.3 Global Botulinum Toxins Market Estimates and Forecasts by Region (2021-2026)

2.3.1 Global Botulinum Toxins Sales Estimates and Forecasts by Region (2021-2026)

2.3.2 Global Botulinum Toxins Revenue Forecast by Region (2021-2026)

2.4 Geographic Market Analysis: Market Facts & Figures

2.4.1 United States Botulinum Toxins Estimates and Projections (2015-2026)

2.4.2 Europe Botulinum Toxins Estimates and Projections (2015-2026)

2.4.3 China Botulinum Toxins Estimates and Projections (2015-2026)

2.4.4 Japan Botulinum Toxins Estimates and Projections (2015-2026)

2.4.5 Southeast Asia Botulinum Toxins Estimates and Projections (2015-2026)

2.4.6 India Botulinum Toxins Estimates and Projections (2015-2026)

3 Global Botulinum Toxins Competition Landscape by Players

3.1 Global Top Botulinum Toxins Players by Sales (2015-2020)

3.2 Global Top Botulinum Toxins Players by Revenue (2015-2020)

3.3 Global Botulinum Toxins Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Botulinum Toxins as of 2019)

3.4 Global Botulinum Toxins Average Price by Company (2015-2020)

3.5 Manufacturers Botulinum Toxins Manufacturing Sites, Area Served, Product Type

3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3.7 Primary Interviews with Key Botulinum Toxins Players (Opinion Leaders)

4 Global Botulinum Toxins Market Size by Type

4.1 Global Botulinum Toxins Historic Market Review by Type (2015-2020)

4.1.1 Global Botulinum Toxins Sales Market Share by Type (2015-2020)

4.1.2 Global Botulinum Toxins Revenue Market Share by Type (2015-2020)

4.1.3 Global Botulinum Toxins Price by Type (2014-2020)

4.2 Global Botulinum Toxins Market Estimates and Forecasts by Type (2021-2026)

4.2.1 Global Botulinum Toxins Sales Forecast by Type (2021-2026)

4.2.2 Global Botulinum Toxins Revenue Forecast by Type (2021-2026)

4.2.3 Global Botulinum Toxins Price Forecast by Type (2021-2026)

5 Global Botulinum Toxins Market Size by Application

5.1 Global Botulinum Toxins Historic Market Review by Application (2015-2020)

5.1.1 Global Botulinum Toxins Sales Market Share by Application (2015-2020)

5.1.2 Global Botulinum Toxins Revenue Market Share by Application (2015-2020)

5.1.3 Global Botulinum Toxins Price by Application (2015-2020)

5.2 Global Botulinum Toxins Market Estimates and Forecasts by Application (2021-2026)

5.2.1 Global Botulinum Toxins Sales Forecast by Application (2021-2026)

5.2.2 Global Botulinum Toxins Revenue Forecast by Application (2021-2026)

5.2.3 Global Botulinum Toxins Price Forecast by Application (2021-2026)

3 North America Botulinum Toxins Market Facts & Figures

3.2 North America Botulinum Toxins Sales Market Share by Company (2015-2020)

3.3 North America Botulinum Toxins Sales Market Share by Type (2015-2020)

3.4 North America Botulinum Toxins Sales Market Share by Application (2015-2020)

4 Europe Botulinum Toxins Market Facts & Figures

4.2 Europe Botulinum Toxins Sales Market Share by Company (2015-2020)

4.3 Europe Botulinum Toxins Sales Market Share by Type (2015-2020)

4.4 Europe Botulinum Toxins Sales Market Share by Application (2015-2020)

5 China Botulinum Toxins Market Facts & Figures

5.2 China Botulinum Toxins Sales Market Share by Company (2015-2020)

5.3 China Botulinum Toxins Sales Market Share by Type (2015-2020)

5.4 China Botulinum Toxins Sales Market Share by Application (2015-2020)

6 Japan Botulinum Toxins Market Facts & Figures

6.2 Japan Botulinum Toxins Sales Market Share by Company (2015-2020)

6.3 Japan Botulinum Toxins Sales Market Share by Type (2015-2020)

6.4 Japan Botulinum Toxins Sales Market Share by Application (2015-2020)

7 Southeast Asia Botulinum Toxins Market Facts & Figures

7.2 Southeast Asia Botulinum Toxins Sales Market Share by Company (2015-2020)

7.3 Southeast Asia Botulinum Toxins Sales Market Share by Type (2015-2020)

7.4 Southeast Asia Botulinum Toxins Sales Market Share by Application (2015-2020)

8 India Botulinum Toxins Market Facts & Figures

8.2 India Botulinum Toxins Sales Market Share by Company (2015-2020)

8.3 India Botulinum Toxins Sales Market Share by Type (2015-2020)

8.4 India Botulinum Toxins Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Botulinum Toxins Business

12.1 Allergan

12.1.1 Allergan Botulinum Toxins Corporation Information

12.1.2 Allergan Botulinum Toxins Business Overview and Total Revenue

12.1.3 Allergan Botulinum Toxins Sales, Revenue and Gross Margin (2015-2020)

12.1.4 Allergan Botulinum Toxins Products Offered

12.1.5 Allergan Recent Development

12.2 Ipsen

12.2.1 Ipsen Botulinum Toxins Corporation Information

12.2.2 Ipsen Botulinum Toxins Business Overview and Total Revenue

12.2.3 Ipsen Botulinum Toxins Sales, Revenue and Gross Margin (2015-2020)

12.2.4 Ipsen Botulinum Toxins Products Offered

12.2.5 Ipsen Recent Development

12.3 Medytox

12.3.1 Medytox Botulinum Toxins Corporation Information

12.3.2 Medytox Botulinum Toxins Business Overview and Total Revenue

12.3.3 Medytox Botulinum Toxins Sales, Revenue and Gross Margin (2015-2020)

12.3.4 Medytox Botulinum Toxins Products Offered

12.3.5 Medytox Recent Development

12.4 LIBP

12.4.1 LIBP Botulinum Toxins Corporation Information

12.4.2 LIBP Botulinum Toxins Business Overview and Total Revenue

12.4.3 LIBP Botulinum Toxins Sales, Revenue and Gross Margin (2015-2020)

12.4.4 LIBP Botulinum Toxins Products Offered

12.4.5 LIBP Recent Development

12.5 Merz Pharmaceuticals

12.5.1 Merz Pharmaceuticals Botulinum Toxins Corporation Information

12.5.2 Merz Pharmaceuticals Botulinum Toxins Business Overview and Total Revenue

12.5.3 Merz Pharmaceuticals Botulinum Toxins Sales, Revenue and Gross Margin (2015-2020)

12.5.4 Merz Pharmaceuticals Botulinum Toxins Products Offered

12.5.5 Merz Pharmaceuticals Recent Development

12.6 US World Meds

12.6.1 US World Meds Botulinum Toxins Corporation Information

12.6.2 US World Meds Botulinum Toxins Business Overview and Total Revenue

12.6.3 US World Meds Botulinum Toxins Sales, Revenue and Gross Margin (2015-2020)

12.6.4 US World Meds Botulinum Toxins Products Offered

12.6.5 US World Meds Recent Development

13 Botulinum Toxins Manufacturing Cost Analysis

13.1 Botulinum Toxins Key Raw Materials Analysis

13.1.1 Key Raw Materials

13.1.2 Key Raw Materials Price Trend

13.1.3 Key Suppliers of Raw Materials

13.2 Proportion of Manufacturing Cost Structure

13.3 Manufacturing Process Analysis of Botulinum Toxins

13.4 Botulinum Toxins Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

14.1 Marketing Channel

14.2 Botulinum Toxins Distributors List

14.3 Botulinum Toxins Customers

15 Market Dynamics

15.1 Market Trends

15.2 Opportunities and Drivers

15.3 Challenges

15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix

17.1 Research Methodology

17.1.1 Methodology/Research Approach

17.1.2 Data Source

17.2 Author List

17.3 Disclaimer

List of Tables

Table 1. Global Botulinum Toxins Sales (K Units) Growth Rate by Type (2020-2026)

Table 2. Global Botulinum Toxins Sales (K Units) Comparison by Application (2020-2026)

Table 3. COVID-19 Impact Global Market: (Four Botulinum Toxins Market Size Forecast Scenarios)

Table 4. Opportunities and Trends for Botulinum Toxins Players in the COVID-19 Landscape

Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis

Table 6. Key Regions/Countries Measures against Covid-19 Impact

Table 7. Proposal for Botulinum Toxins Players to Combat Covid-19 Impact

Table 8. Global Market Botulinum Toxins Market Size (US$ Million) by Region:2015 VS 2020 &2026

Table 9. Global Botulinum Toxins Sales (K Units) by Region (2015-2020)

Table 10. Global Botulinum Toxins Sales Market Share by Region (2015-2020)

Table 11. Global Botulinum Toxins Revenue (US$ Million) Market Share by Region (2015-2020))

Table 12. Global Botulinum Toxins Revenue Share by Region (2015-2020)

Table 13. Global Botulinum Toxins Sales (K Units) Forecast by Region (2021-2026)

Table 14. Global Botulinum Toxins Sales Market Share Forecast by Region (2021-2026)

Table 15. Global Botulinum Toxins Revenue (US$ Million) Forecast by Region (2021-2026)

Table 16. Global Botulinum Toxins Revenue Share Forecast by Region (2021-2026)

Table 17. Global Botulinum Toxins (K Units) of Key Companies (2015-2020)

Table 18. Global Botulinum Toxins Sales Share by Company (2015-2020)

Table 19. Global Botulinum Toxins Revenue (US$ Million) by Company (2015-2020)

Table 20. Global Botulinum Toxins Revenue Share by Company (2015-2020)

Table 21. Global Botulinum Toxins by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Botulinum Toxins as of 2019)

Table 22. Global Botulinum Toxins Average Price (USD/Unit) of Key Company (2015-2020)

Table 23. Manufacturers Botulinum Toxins Manufacturing Sites and Area Served

Table 24. Manufacturers Botulinum Toxins Product Type

Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 26. Main Points Interviewed from Key Botulinum Toxins Players

Table 27. Global Botulinum Toxins Sales (K Units) by Type (2015-2020)

Table 28. Global Botulinum Toxins Sales Share by Type (2015-2020)

Table 29. Global Botulinum Toxins Revenue (US$ Million) Market Share by Type (2015-2020)

Table 30. Global Botulinum Toxins Price (K Units) by Type (2015-2020)

Table 31. Global Botulinum Toxins Sales Share by Type (2021-2026)

Table 32. Global Botulinum Toxins Revenue (US$ Million) Market Share by Type (2021-2026)

Table 33. Global Botulinum Toxins Revenue Share by Type (2021-2026)

Table 34. Global Botulinum Toxins Price (K Units) by Type (2021-2026)

Table 35. Global Botulinum Toxins Sales (K Units) by Application (2015-2020)

Table 36. Global Botulinum Toxins Sales Share by Application (2015-2020)

Table 37. Global Botulinum Toxins Revenue (US$ Million) Market Share by Application (2015-2020)

Table 38. Global Botulinum Toxins Price (K Units) by Application (2015-2020)

Table 39. Global Botulinum Toxins Sales (K Units) by Application (2021-2026)

Table 40. Global Botulinum Toxins Sales Share by Application (2021-2026)

Table 41. Global Botulinum Toxins Revenue (US$ Million) Market Share by Application (2021-2026)

Table 42. Global Botulinum Toxins Revenue Share by Application (2021-2026)

Table 43. Global Botulinum Toxins Price (K Units) by Application (2021-2026)

Table 44. United States Botulinum Toxins Sales (K Units) by Company (2015-2020)

Table 45. United States Botulinum Toxins Sales Market Share by Company (2015-2020)

Table 46. United States Botulinum Toxins Sales (K Units) by Type (2015-2020)

Table 47. United States Botulinum Toxins Sales Market Share by Type (2015-2020)

Table 48. United States Botulinum Toxins Sales (K Units) by Application (2015-2020)

Table 49. United States Botulinum Toxins Sales Market Share by Application (2015-2020)

Table 50. Europe Botulinum Toxins Sales (K Units) by Company (2015-2020)

Table 51. Europe Botulinum Toxins Sales Market Share by Company (2015-2020)

Table 52. Europe Botulinum Toxins Sales (K Units) by Type (2015-2020)

Table 53. Europe Botulinum Toxins Sales Market Share by Type (2015-2020)

Table 54. Europe Botulinum Toxins Sales (K Units) by Application (2015-2020)

Table 55. Europe Botulinum Toxins Sales Market Share by Type (2015-2020)

Table 56. China Botulinum Toxins Sales (K Units) by Company (2015-2020)

Table 57. China Botulinum Toxins Sales Market Share by Company (2015-2020)

Table 58. China Botulinum Toxins Sales (K Units) by Type (2015-2020)

Table 59. China Botulinum Toxins Sales Market Share by Type (2015-2020)

Table 60. China Botulinum Toxins Sales (K Units) by Application (2015-2020)

Table 61. China Botulinum Toxins Sales Market Share by Application (2015-2020)

Table 62. Japan Botulinum Toxins Sales (K Units) by Company (2015-2020)

Table 63. Japan Botulinum Toxins Sales Market Share by Company (2015-2020)

Table 64. Japan Botulinum Toxins Sales (K Units) by Type (2015-2020)

Table 65. Japan Botulinum Toxins Sales Market Share by Type (2015-2020)

Table 66. Japan Botulinum Toxins Sales (K Units) by Application (2015-2020)

Table 67. Japan Botulinum Toxins Sales Market Share by Application (2015-2020)

Table 68. Southeast Asia Botulinum Toxins Sales (K Units) by Company (2015-2020)

Table 69. Southeast Asia Botulinum Toxins Sales Market Share by Company (2015-2020)

Table 70. Southeast Asia Botulinum Toxins Sales (K Units) by Type (2015-2020)

Table 71. Southeast Asia Botulinum Toxins Sales Market Share by Type (2015-2020)

Table 72. Southeast Asia Botulinum Toxins Sales (K Units) by Type (2015-2020)

Table 73. Southeast Asia Botulinum Toxins Sales Market Share by Application (2015-2020)

Table 74. India Botulinum Toxins Sales (K Units) by Company (2015-2020)

Table 75. India Botulinum Toxins Sales Market Share by Company (2015-2020)

Table 76. India Botulinum Toxins Sales (K Units) by Type (2015-2020)

Table 77. India Botulinum Toxins Sales Market Share by Type (2015-2020)

Table 78. India Botulinum Toxins Sales (K Units) by Application (2015-2020)

Table 79. India Botulinum Toxins Sales Market Share by Application (2015-2020)

Table 80. Allergan Corporation Information

Table 81. Allergan Description and Business Overview

Table 82. Allergan Botulinum Toxins Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)

Table 83. Allergan Botulinum Toxins Product

Table 84. Allergan Recent Development

Table 85. Ipsen Corporation Information

Table 86. Ipsen Description and Business Overview

Table 87. Ipsen Botulinum Toxins Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)

Table 88. Ipsen Botulinum Toxins Product

Table 89. Ipsen Recent Development

Table 90. Medytox Corporation Information

Table 91. Medytox Description and Business Overview

Table 92. Medytox Botulinum Toxins Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)

Table 93. Medytox Botulinum Toxins Product

Table 94. Medytox Recent Development

Table 95. LIBP Corporation Information

Table 96. LIBP Description and Business Overview

Table 97. LIBP Botulinum Toxins Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)

Table 98. LIBP Botulinum Toxins Product

Table 99. LIBP Recent Development

Table 100. Merz Pharmaceuticals Corporation Information

Table 101. Merz Pharmaceuticals Description and Business Overview

Table 102. Merz Pharmaceuticals Botulinum Toxins Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)

Table 103. Merz Pharmaceuticals Botulinum Toxins Product

Table 104. Merz Pharmaceuticals Recent Development

Table . US World Meds Corporation Information

Table . US World Meds Description and Business Overview

Table . US World Meds Botulinum Toxins Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)

Table . US World Meds Botulinum Toxins Product

Table . US World Meds Recent Development

Table 110. Production Base and Market Concentration Rate of Raw Material

Table 111. Key Suppliers of Raw Materials

Table 112. Botulinum Toxins Distributors List

Table 113. Botulinum Toxins Customers List

Table 114. Market Key Trends

Table 115. Key Opportunities and Drivers: Impact Analysis (2020-2026)

Table 116. Key Challenges

Table 117. Research Programs/Design for This Report

Table 118. Key Data Information from Secondary Sources

Table 119. Key Data Information from Primary Sources

List of Figures

Figure 1. Botulinum Toxins Product Picture

Figure 2. Global Botulinum Toxins Sales Market Share by Type in 2020 & 2026

Figure 3. Type I Product Picture

Figure 4. Type II Product Picture

Figure 5. Global Botulinum Toxins Market Share by Application in 2020 & 2026

Figure 6. Medical Examples

Figure 7. Cosmetic Examples

Figure 8. Global Botulinum Toxins Sales (K Units) Growth Rate (2015-2026)

Figure 9. Global Botulinum Toxins Revenue (US$ Million) Growth Rate (2015-2026)

Figure 10. Global Botulinum Toxins Price Trends Growth Rate (2015-2026) (USD/Unit)

Figure 11. Global Botulinum Toxins Revenue Market Share by Region: 2015 VS 2020

Figure 12. Global Botulinum Toxins Revenue Market Share by Region: 2021 VS 2026

Figure 13. United States Botulinum Toxins Revenue (Million USD) Growth Rate (2015-2026)

Figure 14. United States Botulinum Toxins Sales (K Units) Growth Rate (2015-2026)

Figure 15. Europe Botulinum Toxins Revenue (Million USD) Growth Rate (2015-2026)

Figure 16. Europe Botulinum Toxins Sales (Million USD) Growth Rate (2015-2026)

Figure 17. China Botulinum Toxins Revenue (Million USD) Growth Rate (2015-2026)

Figure 18. China Botulinum Toxins Sales (Million USD) and Growth Rate (2015-2026)

Figure 19. Japan Botulinum Toxins Revenue (Million USD) Growth Rate (2015-2026)

Figure 20. Japan Botulinum Toxins Sales (Million USD) Growth Rate (2015-2026)

Figure 21. Southeast Asia Botulinum Toxins Revenue (Million USD) Growth Rate (2015-2026)

Figure 22. Southeast Asia Botulinum Toxins Sales (Million USD) Growth Rate (2015-2026)

Figure 23. India Botulinum Toxins Revenue (Million USD) Growth Rate (2015-2026)

Figure 24. India Botulinum Toxins Sales (Million USD) Growth Rate (2015-2026)

Figure 25. Global 5 Largest Botulinum Toxins Players Market Share by Revenue in Botulinum Toxins 2015 & 2019

Figure 26. Botulinum Toxins Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019

Figure 27. Global Botulinum Toxins Revenue Share by Type (2015-2020)

Figure 28. Global Botulinum Toxins Revenue Growth Rate by Type in 2015 & 2019

Figure 29. Global Botulinum Toxins Revenue Share by Application (2015-2020)

Figure 30. Global Botulinum Toxins Revenue Growth Rate by Application in 2015 & 2019

Figure 31. United States Botulinum Toxins Sales Market Share by Type in 2019

Figure 32. United States Botulinum Toxins Sales Market Share by Type in 2019

Figure 33. Europe Botulinum Toxins Sales Market Share by Company in 2019

Figure 34. Europe Botulinum Toxins Sales Market Share by Type in 2019

Figure 35. Europe Botulinum Toxins Sales Market Share by Application in 2019

Figure 36. China Botulinum Toxins Sales Market Share by Company in 2019

Figure 37. China Botulinum Toxins Sales Market Share by Type in 2019

Figure 38. China Botulinum Toxins Sales Market Share by Application in 2019

Figure 39. Japan Botulinum Toxins Sales Market Share by Company in 2019

Figure 40. Japan Botulinum Toxins Sales Market Share by Type in 2019

Figure 41. Japan Botulinum Toxins Sales Market Share by Application in 2019

Figure 42. Southeast Asia Botulinum Toxins Sales Market Share by Company in 2019

Figure 43. Southeast Asia Botulinum Toxins Sales Market Share by Type in 2019

Figure 44. Southeast Asia Botulinum Toxins Sales Market Share by Application in 2019

Figure 45. India Botulinum Toxins Sales Market Share by Company in 2019

Figure 46. India Botulinum Toxins Sales Market Share by Type in 2019

Figure 47. India Botulinum Toxins Sales Market Share by Application in 2019

Figure 48. Allergan Total Revenue (US$ Million): 2019 Compared with 2018

Figure 49. Ipsen Total Revenue (US$ Million): 2019 Compared with 2018

Figure 50. Medytox Total Revenue (US$ Million): 2019 Compared with 2018

Figure 51. LIBP Total Revenue (US$ Million): 2019 Compared with 2018

Figure 52. Merz Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018

Figure 53. US World Meds Total Revenue (US$ Million): 2019 Compared with 2018

Figure 54. Key Raw Materials Price Trend

Figure 55. Manufacturing Cost Structure of Botulinum Toxins

Figure 56. Manufacturing Process Analysis of Botulinum Toxins

Figure 57. Botulinum Toxins Industrial Chain Analysis

Figure 58. Channels of Distribution

Figure 59. Distributors Profiles

Figure 60. Porter's Five Forces Analysis

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed